Documenti analoghi

• Extension Study With rVIII‐SingleChain in Previously Untreated Patients (PUPs) With Severe Haemophilia A
  di: Johnny Mahlangu, et al.
  Pubblicazione: (2025)
• Correction to “Extension Study With rVIII‐SingleChain in Previously Untreated Patients (PUPs) With Severe Hemophilia A”
  Pubblicazione: (2025)
• Estimating the Factor VIII‐Equivalent Activity of Emicizumab Using Global Assays of Haemostasis
  di: Daniel Kraemmer, et al.
  Pubblicazione: (2025)
• Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective
  di: Wolfgang Miesbach, et al.
  Pubblicazione: (2024)
• Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review
  di: Cihan Ay, et al.
  Pubblicazione: (2024)